Hib vaccine conjugate - Heber Biotec
Alternative Names: QuimiHibLatest Information Update: 28 Feb 2014
Price :
$50 *
At a glance
- Originator Heber Biotec
- Developer Cuban Center for Genetic Engineering and Biotechnology; Heber Biotec
- Class Conjugate vaccines; Haemophilus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Haemophilus infections